Centre for HIV & STIs, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
PLoS One. 2019 Jun 26;14(6):e0216033. doi: 10.1371/journal.pone.0216033. eCollection 2019.
South Africa is considered highly endemic for hepatitis A virus (HAV) although few seroprevalence studies have been conducted over the past two decades. The World Health Organization recommends integrating HAV vaccination into national childhood immunization schedules where there is transition from high to intermediate endemicity. As a means of gauging age-specific rates of infection, we report HAV seroprevalence rates among specimens tested for HAV serology within South Africa's public health sector from 2005-2015.
Hepatitis A serology results (Anti-HAV IgM, IgG and total antibody) from 2005-2015 were extracted from South Africa's National Health Laboratory Service's Corporate Data Warehouse (NHLS CDW), the central data repository of all laboratory test-sets within the public health sector. Results were extracted according to test-set, result, date of testing, health facility, name, surname, age, and sex. Anti-HAV IgG results were merged with total antibody results to reflect anti-HAV seroprevalence. Testing volume, positivity rates and age-specific anti-HAV seroprevalence rates by year and geographic distribution are described.
A total of 501 083 HAV IgM results were retrieved, of which 16 423 (3.3%) were positive, 484 259 (96.6%) negative and 401 (0.1%) equivocal; and 34 710 HAV total antibody/IgG tests of which 30 675 (88.4%) were positive, 4 020 (11.6%) negative and 15 equivocal. Whereas IgM positivity was highest among the 1-4 year age group (33.5%) and lowest among patients >45 years (<0.5%), total antibody positivity ranged from its lowest level of 52.7% in the 1-4 year age group increasing to levels of >90% only after 25 years of age.
Anti-HAV total antibody testing within the South African public health sector demonstrates seroprevalence rates reach levels >90% only in adulthood, suggesting South Africa could be in transition from high to intermediate endemicity. Prospective studies with geographically representative sampling are required to confirm these findings and evaluate provincial and urban/rural heterogeneity.
尽管在过去的二十年中进行了少数几项血清流行率研究,但南非被认为是甲型肝炎病毒(HAV)的高度流行地区。世界卫生组织建议在从高流行地区向中流行地区过渡的国家将 HAV 疫苗接种纳入国家儿童免疫规划。作为衡量特定年龄感染率的一种手段,我们报告了南非公共卫生部门 2005-2015 年期间进行的甲型肝炎血清学检测标本中的 HAV 血清流行率。
从南非国家卫生实验室服务公司的数据仓库(NHLS CDW)中提取了 2005-2015 年的甲型肝炎血清学结果(抗-HAV IgM、IgG 和总抗体),该数据仓库是公共卫生部门所有实验室检测集的中央数据存储库。结果根据检测集、结果、检测日期、卫生机构、姓名、姓氏、年龄和性别进行提取。将抗-HAV IgG 结果与总抗体结果合并,以反映抗-HAV 血清流行率。描述了每年和地理分布的检测量、阳性率和特定年龄的抗-HAV 血清流行率。
共检索到 501 083 份 HAV IgM 结果,其中阳性 16 423 份(3.3%),阴性 484 259 份(96.6%),不确定 401 份(0.1%);共检测 34 710 份 HAV 总抗体/IgG,其中阳性 30 675 份(88.4%),阴性 4 020 份(11.6%),不确定 15 份。虽然 IgM 阳性率在 1-4 岁年龄组最高(33.5%),而在>45 岁的患者中最低(<0.5%),但总抗体阳性率从 1-4 岁年龄组的最低水平 52.7%逐渐升高,仅在 25 岁以后才达到>90%的水平。
南非公共卫生部门的抗-HAV 总抗体检测表明,血清流行率仅在成年后达到>90%,这表明南非可能正在从高流行地区向中流行地区过渡。需要进行具有地理代表性抽样的前瞻性研究,以确认这些发现并评估省级和城乡差异。